Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Horizon Therapeutics (NQ: HZNP )

115.61 +0.11 (+0.09%)
Streaming Delayed Price Updated: 2:15 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Horizon Therapeutics

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Tesla On Tap: "Mega-cap" Reporting Season Gets Underway After Close With EV Giant's Earnings
(Wednesday market open) Major indexes ride into Tesla’s (NASDAQ: TSLA) earnings later today on a long winning streak that carried stocks to new 15-month highs yesterday. Hopes for an economic “soft... 
Via Benzinga
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout
Activision stock rocketed after a court allowed Microsoft to proceed with its $69 billion acquisition of the video game publisher. 
Via Investor's Business Daily
Why Shares of Viridian Therapeutics Are Falling Tuesday
The company announced preliminary trial results for its lead therapy. 
Via The Motley Fool
Viridian Wants To Take On Horizon; Why This Update In Thyroid Eye Disease Fell Flat
Shares tumbled after the biotech company unveiled the results of its chronic TED treatment. 
Via Investor's Business Daily
Is Amgen a Good Dividend Stock?
The biotech's yield is near an all-time high right now. 
Via The Motley Fool
A Look Into Horizon Therapeutics' Debt
Via Benzinga
Why Horizon Therapeutics Stock Is Crashing Today
The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen. 
Via The Motley Fool
Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns
(Thursday market open) Things are heating up, and we’re not just talking about the July weather. A week from the start of Q2 earnings season, Wall Street is on tenterhooks awaiting tomorrow’s crucial... 
Via Benzinga
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
What Will Amgen Buy Next?
The biotech could pursue these two budget-friendly targets. 
Via The Motley Fool
Why Amgen Stock Slumped on Monday
Already under fire on the regulatory front, the company is hit with a price-target cut. 
Via The Motley Fool
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds. 
Via The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling. 
Via InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Should Pfizer and Seagen investors be worried? 
Via The Motley Fool
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
Chips, software and AI plays were strong. But leadership remains narrow. 
Via Investor's Business Daily
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN)  
Via Benzinga
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) shares dropped sharply on Tuesday following a report suggesting the FTC is expected to file a complaint to block Amgen's 
Via Benzinga
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet. 
Via The Motley Fool
Is This Dow Jones Stock a Buy for Income Investors?
This pharmaceutical company is dedicated to maintaining its track record of innovation. 
Via The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today. 
Via The Motley Fool
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
In a rare move to block a large pharma deal, the U.S. 
Via Benzinga
Dow Down More Than 200 Points On Blue Chip Earnings
Stocks are all over the place midday. 
Via Talk Markets
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
Their declines weighed on the broader market. 
Via The Motley Fool
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares. 
Via InvestorPlace
Seagen (SGEN) Stock Falls 6% After Director Sells Shares
Seagen (SGEN) stock is slipping on Tuesday after one of the company's directors sold shares worth more than $372,000 on Monday. 
Via InvestorPlace
Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories
Benzinga Former SVB Chief Blames Fed, Media Hype For Bank's Devastating Collapse 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.